Home | Links | Contact Us | More About Intellectual Property | Bookmark

Search patents:

Home

Gene Therapy

Method-for-identifying-an-oligonucleotide-aptamer-specific-for-a-target

Pharmaceutical composition for treatment of adult respiratory distress syndrome containing human ANP

The present invention has been accomplished under these circumstances and has as an object ...

Peptide, a method for its preparation and a pharmaceutical composition containing the peptide

OF THE PREFERRED EMBODIMENT The following standard abbreviations for the amino acid residues are ...

Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX

The invention provides an isolated peptide that functionally mimics a binding site for a ...

Adjuvant and vaccine compositions containing monophosphoryl lipid A

What is claimed: 1. A lyophilized composition comprising 0.2% up to 5% by weight 3-O-desacyl-4'-...

Methods for preparation of vaccines against cancer

The present invention relates to methods for producing increased amounts of immunogenic material ...

Human genes and gene expression products V

OF THE INVENTION The invention relates to polynucleotides comprising the disclosed nucleotide ...

Haptotactic peprides

The invention claimed is: 1. An isolated haptotactic peptide of 20 amino acids consisting of the ...

Hepatitis C virus inhibitors

OF THE INVENTION Stereochemical definitions and conventions used herein generally follow McGraw-H...

Expression of recombinant glyoprotein B from herpes simplex virus

The nucleotide sequence and the amino acid sequence derived therefrom are provided for Herpes S...

Enhancing agent for nerve growth factor production comprising a compound having a coumarin backbone or a compound having a 2-dimethyl chroman backbone

The invention claimed is: 1. A therapeutic agent or prophylactic agent for a disease requiring ...

Method for identifying an oligonucleotide aptamer specific for a target

Details

Inventors: Toole, John J.; Latham, John; Bock, Louis C.; Griffin, Linda C.;
Assignee: Gilead Sciences, Inc. (Foster City, CA)
Primary Examiner: Zitomer; Stephanie W.
Assistant Examiner:
Attorney, Agent or Firm: Muenchau; Daryl D.

A method for identifying oligomer sequences which specifically bind target biomolecules is described. The technique involves complexation of the support-bound target molecule with a mixture of oligonucleotides containing random sequences and sequences which serve as primer for PCR under conditions wherein a complex is formed with the specifically binding sequences, but not with the other members of the oligonucleotide mixture. The target-oligonucleotide complexes are then separated from both the support and the uncomplexed oligonucleotides and the complexed members of the oligonucleotide mixture are recovered from the separated complex and subsequently amplified using the polymerase chain reaction. The recovered oligonucleotides may be sequenced, and successive rounds of selection using complexation, separation, amplification and recovery can be employed.

DETAILED DESCRIPTION We claim: 1.
A method for identifying an aptamer which specifically binds to thrombin, wherein the aptamer comprises the sequence 5' GGNTGG 3' wherein N is A, T Or G which method comprises: (a) incubating thrombin reversibly coupled to a support with a randomized mixture of single-stranded DNA oligonucleotide sequences under conditions wherein the member of the mixture to form a support-bound oligonucleotide-thrombin complex; (b) decoupling and recovering support-bound oligonucleotide-thrombin complex to form a free oligonucleotide-thrombin complex; (c) recovering free oligonucleotide from the free oligonucleotide-thrombin complex and recovering and amplifying the free oligonucleotide; and (d) optionally determining the sequence of the recovered oligonucleotide.
2.
The method of claim 1 wherein N is T.
3.
The method of claim 1 wherein the aptamer comprises the sequence 5' GGNTGG(N).
sub.
Z GGNTGG 3' wherein Z is an integer from 2 to 5.
4.
The method of claim 3 wherein Z is 3.
5.
The method of claim 4 wherein the aptamer comprises the sequence 5' GGNTGGTGTGGNTGG 3'.
6.
The method of claim 5 wherein N is T.
7.
The method of claim 1 wherein the support is a lectin column.
8.
The method of claim 1 wherein the support is a solid support.
9.
The method of claim 1 wherein the solid support comprises agarose or sepharose.
10.
The method of claim 3 wherein the support is a lectin column.
11.
The method of claim 3 wherein the support is a solid support.
12.
The method of claim 3 wherein the solid support comprises agarose or sepharose.

Description:
TECHNICAL FIELD The present invention is directed to a method for identifying oligonucleotide sequences which specifically bind target molecules.
More specifically, the invention concerns an improved method to identify specific binding oligonucleotide sequences by incubating a pool of oligonucleotides with support-bound target molecules and detaching the resulting target-oligonucleotide complexes from the support.
BACKGROUND AND RELATED ART Conventional methods of detection and isolation of proteins and other molecules have employed antibodies and the like which specifically bind such substances

Related patents

	Plant transcription regulators from circovirus OF THE INVENTION The present invention is further described by reference to the following non-limiting figures and/or examples. Reference herein to a promoter region ...
	Methods for modulation of the effects of aging on the primate brain The invention provides a clinically useful protocol for delivery of recombinant nervous system growth factors into the aging mammalian brain. The invention is ...
	Genetic engineering of cells to enhance healing and tissue regeneration OF THE INVENTION It has been discovered that cells can be genetically engineered to produce bioactive molecules which act on the cells that are expressing the molecules,...
	Vascular endothelial growth factor-D (VEGF-D) polypeptides OF THE INVENTION The invention will now be described in detail by reference to the figures, and to the following non-limiting examples. EXAMPLE 1 It has been speculated ...
	Methods for treating viral infection using IL-28 and IL-29 We claim: 1. A method of treating a viral infection comprising administering to an immunocompromised mammal with a hepatitis infection a therapeutically effective amount ...
	Method of manufacturing an electrohydraulic probe OF THE INVENTION Referring to FIG. 1 there is shown a diagrammatical view of the bladder 2, ureter 4 and kidney 6 areas of a patient having a lithotriptoscope 8 moving ...
	Releasable linkage and compositions containing same Accordingly, it is an object of the invention to provide a compound where a ligand is covalently yet reversibly linked to a hydrophilic polymer. Upon cleavage of the ...
	Solid phase dispersion of quinolone or naphthyridonecarboxylic acids What is claimed is: 1. A solid phase dispersion comprising a micronized quinolinecarboxylic acid or micronized naphthyridonecarboxylic acid in an insoluble matrix, ...
	Peptide, process for its preparation and pharmaceutical composition containing same We claim: 1. pGlu-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe. 2. A pharmaceutical composition for cell-growth stimulating action comprising an effective amount of the ...
	Stable pharmaceutical composition and method for its production It is an object of the present invention to provide a stable pharmaceutical composition wherein the absorbability of a lipophilic drug which is insoluble or practically ...

0.024
Archive: All patents - Links Copyright (c)2006 Eipa-patents.org - All rights reserved